MedPath

Effectiveness of "Medisinstart"

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Registration Number
NCT02261402
Lead Sponsor
Apokus AS
Brief Summary

"Medisinstart" is a new service developed for use in Norwegian pharmacies. It is intended for patients that are about to start a new medicine for a chronic or long-term condition. It is based on research showing that problems with newly prescribed medicines appear rapidly and that a significant portion of patients quickly becomes non-adherent. The service consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine.

The main purpose of this study is to investigate whether "Medisinstart" increases patients' adherence to the prescribed medication. Patients' beliefs about their medicines and their motivation for adherence will also be examined. The study also aims at revealing if "Medisinstart" has additional benefits for the patient, the society and the pharmacies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1480
Inclusion Criteria

First time prescription for a drug belonging to one of the following groups (ATC-code):

  • Dabigatran etexilate (B01AE07)
  • Rivaroxaban (B01AF01)
  • Apixaban (B01AF02)
  • Beta blocking agents (C07)
  • Calcium channel blockers (C08)
  • Agents acting on the renin-angiotensin system (C09)
  • HMG CoA reductase inhibitors (statins) (C10AA)
Exclusion Criteria
  • Prior use (within the last 3 years) of the drug in question independent of strength, dose and formulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 7 weeks7 weeks after dispensing the new medicine

Adherence will be measured by a validated Norwegian translation of the MMAS-8

Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 18 weeks18 weeks after dispensing the new medicine

Adherence will be measured by a validated Norwegian translation of the MMAS-8

Secondary Outcome Measures
NameTimeMethod
Self reported adherence at 18 weeks18 weeks after dispensing the new medicine

Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?"

Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 18 weeks18 weeks after dispensing the new medicine

Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ

Self reported adherence at 7 weeks7 weeks after dispensing the new medicine

Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?"

Adherence by Medication Possession Ratio (MPR) at 18 weeks18 weeks after dispensing the new medicine

Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database

Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at inclusionAt inclusion

Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ

Adherence by Medication Possession Ratio (MPR) at 1 year1 year after dispensing the new medicine

Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database

Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 7 weeks7 weeks after dispensing the new medicine

Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ

Trial Locations

Locations (67)

Apotek 1 Alta

🇳🇴

Alta, Norway

Apotek 1 Andselv

🇳🇴

Andselv, Norway

Boots apotek Harebakken

🇳🇴

Arendal, Norway

Sykehusapoteket Arendal

🇳🇴

Arendal, Norway

Apotek 1 Horisont

🇳🇴

Bergen, Norway

Boots apotek Bryggen

🇳🇴

Bergen, Norway

Sjukehusapoteket i Bergen

🇳🇴

Bergen, Norway

Sykehusapoteket i Bodø

🇳🇴

Bodø, Norway

Apotek 1 Brandbu

🇳🇴

Brandbu, Norway

Apotek 1 Bømlo

🇳🇴

Bremnes, Norway

Scroll for more (57 remaining)
Apotek 1 Alta
🇳🇴Alta, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.